Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Emmanuelle C. Landmann & Ulrich A. Walker. (2017) Pharmacological treatment options for cryopyrin-associated periodic syndromes. Expert Review of Clinical Pharmacology 10:8, pages 855-864.
Read now
Read now
Sarah R Kingsbury, Philip G Conaghan & Michael F McDermott. (2011) The role of the NLRP3 inflammasome in gout. Journal of Inflammation Research 4, pages 39-49.
Read now
Read now
Justin Gillespie, Rebeccah Mathews & Michael F McDermott. (2010) Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS). Journal of Inflammation Research 3, pages 1-8.
Read now
Read now
Articles from other publishers (52)
Flore Wouters, Jeroen van der Hilst & Jeroen Bogie. (2023) Lipids in inflammasome activation and autoinflammatory disorders. Journal of Allergy and Clinical Immunology.
Crossref
Crossref
Silvia Torices, Leah Daire, Sierra Simon, Luisa Mendoza, Destiny Daniels, Joelle-Ann Joseph, Nikolai Fattakhov, Oandy Naranjo, Timea Teglas & Michal Toborek. (2023) The NLRP3 inflammasome and gut dysbiosis as a putative link between HIV-1 infection and ischemic stroke. Trends in Neurosciences 46:8, pages 682-693.
Crossref
Crossref
Daniela P. Vasconcelos, Artur P. Águas & Judite N. Barbosa. (2022) The inflammasome in biomaterial‐driven immunomodulation. Journal of Tissue Engineering and Regenerative Medicine 16:12, pages 1109-1120.
Crossref
Crossref
Gabriele Fenini, Tugay Karakaya, Paulina Hennig, Michela Di Filippo, Marta Slaufova & Hans-Dietmar Beer. (2022) NLRP1 Inflammasome Activation in Keratinocytes: Increasing Evidence of Important Roles in Inflammatory Skin Diseases and Immunity. Journal of Investigative Dermatology 142:9, pages 2313-2322.
Crossref
Crossref
Hallie M. Blevins, Yiming Xu, Savannah Biby & Shijun Zhang. (2022) The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
A. L. Kozlova, V. I. Burlakov, Z. A. Nesterenko, V. O. Bludova, E. V. Raykina, T. V. Varlamova, М. А. Kurnikova, A. А. Moiseeva, S. А. Dibirova, N. Yu. Kan, А. L. Horeva, А. А. Roppelt, D. V. Yukhacheva, E. V. Deripapa, Yu. А. Rodina, O. A. Shvets, E. A. Deordieva, N. B. Kuzmenko, А. А. Mukhina, G. А. Novichkova & A. Yu. Shcherbina. (2022) Cryopyrin-associated periodic syndrome assess the efficacy and safety of anakinra therapy: a single center experience. Pediatric Hematology/Oncology and Immunopathology 21:1, pages 88-92.
Crossref
Crossref
João P. Luís, Carlos J. V. Simões & Rui M. M. Brito. (2022) The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders. International Journal of Molecular Sciences 23:3, pages 1731.
Crossref
Crossref
Rotem Semo-Oz, Bar Biton & Melissa S. Tesher. (2022) The Role of Anti–IL-1 Medications in Autoinflammatory Disease. Pediatric Annals 51:2.
Crossref
Crossref
Theodoros-Ioannis Papadimitriou, Arjan van Caam, Peter M. van der Kraan & Rogier M. Thurlings. (2022) Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis. Biomedicines 10:2, pages 316.
Crossref
Crossref
Charalampos Skarlis & Clio P. Mavragani. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
479
491
.
Annalisa Marcuzzi, Elisabetta Melloni, Giorgio Zauli, Arianna Romani, Paola Secchiero, Natalia Maximova & Erika Rimondi. (2021) Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity. International Journal of Molecular Sciences 22:20, pages 11241.
Crossref
Crossref
Mengda Xu, Kailun Zhang & Jiangping Song. (2021) Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era. Frontiers in Pharmacology 12.
Crossref
Crossref
Yuichi Yamasaki, Tomohiro Kubota, Syuji Takei, Hiroyuki Imanaka, Yukiko Nonaka & Yoshifumi Kawano. (2020) A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease. Clinical Rheumatology 40:1, pages 393-397.
Crossref
Crossref
Julie T. Marchesan, Mustafa Saadat Girnary, Kevin Moss, Eugenia Timofeev Monaghan, Grant Joseph Egnatz, Yizu Jiao, Shaoping Zhang, Jim Beck & Karen V. Swanson. (2019) Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics. Periodontology 2000 82:1, pages 93-114.
Crossref
Crossref
Jaeseong Oh, Ki Young Huh, Young‐Gyu Cho, Ji‐Eun Cha, Se‐Jin Kim, Seo Hyun Yoon, Sung Sup Park, Hyunyee Yoon, Jieon Lee & Howard Lee. (2020) Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid fc‐fused interleukin‐1 receptor antagonist, in healthy subjects: A first‐in‐human study. British Journal of Clinical Pharmacology 86:2, pages 372-379.
Crossref
Crossref
Adriana A. de Jesus, Polly J. Ferguson & Raphaela Goldbach-Mansky. 2020. Stiehm's Immune Deficiencies. Stiehm's Immune Deficiencies
643
684
.
Charles Anthony Dinarello. (2019) The IL-1 family of cytokines and receptors in rheumatic diseases. Nature Reviews Rheumatology 15:10, pages 612-632.
Crossref
Crossref
Tilmann Kallinich & Fabrizio de Benedetti. 2019. Textbook of Autoinflammation. Textbook of Autoinflammation
751
774
.
Margareta Wikén, Bengt Hallén, Torbjörn Kullenberg & Lisa Osterling Koskinen. (2018) Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study. Clinical Rheumatology 37:12, pages 3381-3386.
Crossref
Crossref
Zuhre Tutuncu & Arthur Kavanaugh. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology
999
1019
.
J. Rojo, A. Sousa-Herves & A. Mascaraque. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
577
610
.
Martina Finetti, Alessia Omenetti, Silvia Federici, Roberta Caorsi & Marco Gattorno. (2016) Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review. Orphanet Journal of Rare Diseases 11:1.
Crossref
Crossref
Michael J. Primiano, Bruce A. Lefker, Michael R. Bowman, Andrea G. Bree, Cedric Hubeau, Paul D. Bonin, Matthew Mangan, Ken Dower, Brian G. Monks, Leah Cushing, Stephen Wang, Julia Guzova, Aiping Jiao, Lih-Ling Lin, Eicke Latz, David Hepworth & J. Perry Hall. (2016) Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation. The Journal of Immunology 197:6, pages 2421-2433.
Crossref
Crossref
Torbjörn Kullenberg, Malin Löfqvist, Mika Leinonen, Raphaela Goldbach-Mansky & Hans Olivecrona. (2016) Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes. Rheumatology 55:8, pages 1499-1506.
Crossref
Crossref
Aldo Naselli, Federica Penco, Luca Cantarini, Antonella Insalaco, Mariolina Alessio, Alberto Tommasini, Cristina Maggio, Laura Obici, Romina Gallizi, Marco Cimmino, Sara Signa, Orso Maria Lucherini, Sonia Carta, Francesco Caroli, Alberto Martini, Anna Rubartelli, Isabella Ceccherini & Marco Gattorno. (2016)
Clinical Characteristics of Patients Carrying the Q703K Variant of the
NLRP3
Gene: A 10-year Multicentric National Study
. The Journal of Rheumatology 43:6, pages 1093-1100.
Crossref
Crossref
Songmao Zheng, Weirong Wang & Honghui Zhou. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
22
.
Jasmin B. Kuemmerle-Deschner. (2015) CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease. Seminars in Immunopathology 37:4, pages 377-385.
Crossref
Crossref
R. N. Khan & D. P. Hay. (2014) A clear and present danger: inflammasomes DAMPing down disorders of pregnancy. Human Reproduction Update 21:3, pages 388-405.
Crossref
Crossref
Giuseppe Lopalco, Luca Cantarini, Antonio Vitale, Florenzo Iannone, Maria Grazia Anelli, Laura Andreozzi, Giovanni Lapadula, Mauro Galeazzi & Donato Rigante. (2015) Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives. Mediators of Inflammation 2015, pages 1-21.
Crossref
Crossref
Raphaela Goldbach-Mansky, Adriana Almeida de Jesus, Michael F. McDermott & Daniel L. Kastner. 2015. Rheumatology. Rheumatology
1369
1391
.
Mark D. Turner, Belinda Nedjai, Tara Hurst & Daniel J. Pennington. (2014) Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:11, pages 2563-2582.
Crossref
Crossref
Adriana A. de Jesus, Polly J. Ferguson & Raphaela Goldbach-Mansky. 2014. Stiehm's Immune Deficiencies. Stiehm's Immune Deficiencies
517
550
.
Charles A. Dinarello & Jos W.M. van der Meer. (2013) Treating inflammation by blocking interleukin-1 in humans. Seminars in Immunology 25:6, pages 469-484.
Crossref
Crossref
Yu-Gang Wang, Wen-Li Fang, Jue Wei, Ting Wang, Na Wang, Jia-Li Ma & Min Shi. (2013) The involvement of NLRX1 and NLRP3 in the development of nonalcoholic steatohepatitis in mice. Journal of the Chinese Medical Association 76:12, pages 686-692.
Crossref
Crossref
William Abramovits & Marcial Oquendo. (2013) Introduction to Autoinflammatory Syndromes and Diseases. Dermatologic Clinics 31:3, pages 363-385.
Crossref
Crossref
Monika Moll & Jasmin B. Kuemmerle-Deschner. (2013) Inflammasome and cytokine blocking strategies in autoinflammatory disorders. Clinical Immunology 147:3, pages 242-275.
Crossref
Crossref
Aris N. Economides & Neil Stahl. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals
143
162
.
Zuhre Tutuncu & Arthur Kavanaugh. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology
957
977.e4
.
Abhijit Chakraborty, Stacey Tannenbaum, Christiane Rordorf, Philip J. Lowe, David Floch, Hermann Gram & Sandip Roy. (2012) Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody. Clinical Pharmacokinetics 51:6, pages e1-e18.
Crossref
Crossref
Marco Gattorno. 2012. Textbook of Clinical Pediatrics. Textbook of Clinical Pediatrics
1701
1711
.
Imad K. Abukhalaf, Daniel A. von Deutsch, Naser A. Ansari & Asma Alsharif. 2012. Handbook of Drug Interactions. Handbook of Drug Interactions
415
475
.
L. Cantarini, O.M. Lucherini, B. Frediani, M.G. Brizi, B. Bartolomei, R. Cimaz, M. Galeazzi & D. Rigante. (2011) Bridging the Gap between the Clinician and the Patient with Cryopyrin-Associated Periodic Syndromes. International Journal of Immunopathology and Pharmacology 24:4, pages 827-836.
Crossref
Crossref
Lori Broderick, Louanne M. Tourangeau, Arthur Kavanaugh & Stephen I. Wasserman. (2011) Biologic modulators in allergic and autoinflammatory diseases. Current Opinion in Allergy & Clinical Immunology 11:4, pages 355-360.
Crossref
Crossref
C. Calvo Rey, P. Soler-Palacín, R. Merino Muñoz, J. Saavedra Lozano, J. Antón López, J.I. Aróstegui, D. Blázquez Gamero, A. Martín-Nalda, M. Juan, M. Méndez, R. Piñeiro Perez & I. Calvo. (2011) Documento de Consenso de la Sociedad de Infectología Pediatrica y la Sociedad de Reumatología Pediatrica sobre el diagnóstico diferencial y el abordaje terapéutico de la fiebre recurrente. Anales de Pediatría 74:3, pages 194.e1-194.e16.
Crossref
Crossref
Jasmin B Kuemmerle-Deschner, Peter Lohse, Ina Koetter, Guenther E Dannecker, Fabian Reess, Katharina Ummenhofer, Silvia Koch, Nikolay Tzaribachev, Anja Bialkowski & Susanne M Benseler. (2011) NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment. Arthritis Research & Therapy 13:6, pages R196.
Crossref
Crossref
Allen Radin, Thomas Marbury, Greg Osgood & Pavel Belomestnov. (2013) Safety and Pharmacokinetics of Subcutaneously Administered Rilonacept in Patients With Well‐Controlled End‐Stage Renal Disease (ESRD). The Journal of Clinical Pharmacology 50:7, pages 835-841.
Crossref
Crossref
Hal M. Hoffman & Alan A. Wanderer. (2010) Inflammasome and IL-1β-Mediated Disorders. Current Allergy and Asthma Reports 10:4, pages 229-235.
Crossref
Crossref
Kate Schroder & Jurg Tschopp. (2010) The Inflammasomes. Cell 140:6, pages 821-832.
Crossref
Crossref
Sushmita Jha & Jenny P.-Y. Ting. (2009) Inflammasome-Associated Nucleotide-Binding Domain, Leucine-Rich Repeat Proteins and Inflammatory Diseases. The Journal of Immunology 183:12, pages 7623-7629.
Crossref
Crossref
Steven Kozlowski, Barry Cherney & Raymond P. Donnelly. (2009) Hurdles and Leaps for Protein Therapeutics. Annals of the New York Academy of Sciences 1182:1, pages 146-160.
Crossref
Crossref
Neil Stahl, Allen Radin & Scott Mellis. (2009) Rilonacept-CAPS and Beyond. Annals of the New York Academy of Sciences 1182:1, pages 124-134.
Crossref
Crossref
Hal M. Hoffman. (2009) Therapy of autoinflammatory syndromes. Journal of Allergy and Clinical Immunology 124:6, pages 1129-1138.
Crossref
Crossref